Department of Pathology, Universitat de València, València, Spain.
Biomedical Research Institute INCLIVA, València, Spain.
Sci Rep. 2020 Mar 16;10(1):4771. doi: 10.1038/s41598-020-61637-4.
Cutaneous melanoma is an aggressive neoplasm and is responsible for the majority of skin cancer deaths. Several miRNAs are involved in melanoma tumor progression. One of them is miR-205, the loss of which contributes to the development of melanoma metastasis. We evaluated whole-genome mRNA expression profiling associated with different miR-205 expression levels in melanoma cells. Differential expression analysis identified 243 differentially expressed transcripts including inositol polyphosphate 5'-phosphatase-like protein-1 (INPPL1) and BTB/POZ Domain-Containing Protein 3 (BTBD3). INPPL1 and BTBD3 were downregulated when melanoma cells expressed miR-205, indicating that these genes are potential miR-205 targets. Additionally, the target prediction algorithm TargetScan revealed that INPPL1 and BTBD3 genes had predicted target sites of miR-205 in their 3'UTRs and functional analysis demonstrated that these genes were directly linked to miR-205. Interestingly, our clinical data showed that INPPL1 was significantly associated with lymph node metastasis-free survival (LNMFS), distant metastasis-free survival (DMFS) and melanoma specific survival (MSS). This study supports INPPL1 as a miR-205 target gene and, therefore, that the involvement of miR-205 in the metastatic dissemination of malignant melanoma is, at least in part, via INPPL1.
皮肤黑色素瘤是一种侵袭性肿瘤,是导致大多数皮肤癌死亡的主要原因。有几种 miRNA 参与黑色素瘤肿瘤的进展。其中之一是 miR-205,其缺失有助于黑色素瘤转移的发展。我们评估了与黑色素瘤细胞中不同 miR-205 表达水平相关的全基因组 mRNA 表达谱。差异表达分析确定了 243 个差异表达的转录本,包括肌醇多磷酸 5′-磷酸酶样蛋白-1(INPPL1)和 BTB/POZ 结构域蛋白 3(BTBD3)。当黑色素瘤细胞表达 miR-205 时,INPPL1 和 BTBD3 下调,表明这些基因是潜在的 miR-205 靶基因。此外,靶标预测算法 TargetScan 表明,INPPL1 和 BTBD3 基因在其 3'UTR 中有 miR-205 的预测靶标,功能分析表明这些基因与 miR-205 直接相关。有趣的是,我们的临床数据表明,INPPL1 与无淋巴结转移生存(LNMFS)、无远处转移生存(DMFS)和黑色素瘤特异性生存(MSS)显著相关。这项研究支持 INPPL1 作为 miR-205 的靶基因,因此 miR-205 参与恶性黑色素瘤的转移扩散至少部分是通过 INPPL1 实现的。